Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats

Area of Science:

• Biomaterials Science
• Translational Medicine
• Medical Device Engineering

Background:

• The rat model is frequently used for evaluating subcutaneous tissue responses to implanted devices.
• Biomaterial biocompatibility and device longevity are influenced by tissue interactions.
• The predictive accuracy of the rat model for human responses remains poorly understood.

Purpose of the Study:

• To compare subcutaneous foreign body responses in rats and humans.
• To monitor the biochemical environment at polymer-tissue interfaces over 8 days.
• To assess the validity of rat models for human biocompatibility studies.

Main Methods:

• Polyamide microdialysis probes were implanted subcutaneously in humans and rats (n=12).
• Daily microdialysis samples were analyzed for glucose, lactate, pyruvate, glycerol, and urea.
• Blood glucose levels were also monitored throughout the 8-day study period.

Main Results:

• Significant differences in analyte concentrations were observed between rats and humans at the implant-tissue interface.
• Qualitative differences in biochemical trends were noted over the 8-day period.
• Human microdialysate glucose increased 2-4 fold, while rat glucose decreased (P < 0.001).

Conclusions:

• Profound physiological differences exist at material-tissue interfaces between rats and humans.
• Extrapolation of subcutaneous rat biocompatibility data to humans requires careful consideration.
• This study underscores the need for cautious interpretation of rat model findings in human medical device development.